Direxion Daily SandP Biotech Bear 3X Shares (LABD) |
| 19.96 0.08 (0.4%) 01-13 16:00 |
| Open: | 20.1 |
| High: | 20.83 |
| Low: | 19.735 |
| Volume: | 2,445,316 |
| Market Cap: | 46(M) |
| PE Ratio: | 0 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management - Leveraged |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 23.01 |
| Resistance 1: | 20.88 |
| Pivot price: | 20.18 |
| Support 1: | 17.44 |
| Support 2: | 14.51 |
| 52w High: | 160.5 |
| 52w Low: | 17.43 |
The fund, under normal circumstances, invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 26 Dec 2025
Why (LABD) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Mon, 22 Dec 2025
How to Trade Biotech’s Volatility with LABU/LABD | CRISPR & Cancer Stocks - ETFguide
Tue, 09 Dec 2025
5 Small-cap Biotech ETFs to Watch - Investing News Network
Wed, 14 May 2025
Top Performing Leveraged/Inverse ETFs: 05/11/2025 - ETF Trends
Thu, 10 Apr 2025
Top Performing Leveraged/Inverse ETFs: 04/06/2025 - ETF Database
Tue, 19 Nov 2024
Top Performing Leveraged/Inverse ETFs: 11/17/2024 - ETF Trends
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
